Literature DB >> 11125184

Investigation of diarrhea in AIDS.

K E Mönkemüller1, C M Wilcox.   

Abstract

Chronic diarrhea is a common problem in patients with acquired immune deficiency syndrome (AIDS), resulting in significant morbidity and potential mortality. In the early stages of immunodeficiency, human immunodeficiency virus (HIV)-infected patients are susceptible to infection with the same enteric pathogens that cause diarrhea in immunocompetent hosts, but with progressive immunodeficiency, these patients become susceptible to numerous opportunistic disorders. The main factor to consider when tailoring the work-up of diarrhea in the HIV-infected patient is the immune status, which is reflected by the total CD4 lymphocyte cell count. A CD4 count of less than 100 cells/microL is significantly correlated with opportunistic disorders. For the HIV-infected patient with diarrhea, repeated stool studies to investigate for bacteria, ova and parasites should be the first step. When either upper or lower gastrointestinal tract symptoms are present and stool studies are negative, endoscopy directed to the probable organ of involvement is appropriate. If localizing symptoms are absent, the most appropriate next test is sigmoidoscopy with biopsies. Not infrequently, despite extensive evaluation, the cause of diarrhea in patients with AIDS remains unexplained. Recently, the widespread use of highly active antiretroviral therapy, including protease inhibitors, has led to a change in the epidemiology of diarrhea in AIDS patients. As their immune status improves, HIV-infected patients treated with combination therapy become less prone to opportunistic disorders. However, diarrhea appears to be frequent because several antiretroviral agents can themselves cause diarrhea.

Entities:  

Mesh:

Year:  2000        PMID: 11125184     DOI: 10.1155/2000/610878

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  5 in total

1.  Double-blind pilot study of mesalamine vs. placebo for treatment of chronic diarrhea and nonspecific colitis in immunocompetent HIV patients.

Authors:  Maribel Rodríguez-Torres; Jose F Rodríguez-Orengo; Carlos F Ríos-Bedoya; Alberto Fernández-Carbia; Rosa Salgado-Mercado; Acisclo M Marxuach-Cuétara
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

2.  Human Immunodeficiency Virus-Associated Diarrhea: Still an Issue in the Era of Antiretroviral Therapy.

Authors:  Andrew E Dikman; Emily Schonfeld; Nalinee C Srisarajivakul; Michael A Poles
Journal:  Dig Dis Sci       Date:  2015-03-14       Impact factor: 3.199

3.  Cryptosporidiosis in HIV-positive patients and related risk factors: A systematic review and meta-analysis.

Authors:  Ehsan Ahmadpour; Hanie Safarpour; Lihua Xiao; Mehdi Zarean; Kareem Hatam-Nahavandi; Aleksandra Barac; Stephane Picot; Mohammad Taghi Rahimi; Salvatore Rubino; Mahmoud Mahami-Oskouei; Adel Spotin; Sanam Nami; Hossein Bannazadeh Baghi
Journal:  Parasite       Date:  2020-04-30       Impact factor: 3.000

4.  Characterization of the Intestinal Fungal Microbiome in HIV and HCV Mono-Infected or Co-Infected Patients.

Authors:  Yue Yin; Maermaer Tuohutaerbieke; Chengjie Feng; Xinjie Li; Yuqi Zhang; Qiang Xu; Jing Tu; Ence Yang; Qinghua Zou; Tao Shen
Journal:  Viruses       Date:  2022-08-18       Impact factor: 5.818

5.  Clinical and Microbiological Profile of HIV/AIDS Cases with Diarrhea in North India.

Authors:  Arun Kumar Jha; Beena Uppal; Sanjim Chadha; Preena Bhalla; Roumi Ghosh; Prabhav Aggarwal; Richa Dewan
Journal:  J Pathog       Date:  2012-12-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.